NCT03509454View on ClinicalTrials.gov

PeRsOnalising Treatment Of Diabetic Nephropathy:

CompletedOBSERVATIONAL
Enrollment

210

Participants

Timeline

Start Date

April 1, 2016

Primary Completion Date

October 1, 2017

Study Completion Date

April 1, 2018

Conditions
Diabetes Mellitus, Type 1Diabetes ComplicationsDiabetic Nephropathies
Trial Locations (1)

2820

Steno Diabetes Center, Gentofte Municipality

All Listed Sponsors
lead

Peter Rossing

OTHER

NCT03509454 - PeRsOnalising Treatment Of Diabetic Nephropathy: | Biotech Hunter | Biotech Hunter